BCR/ABL Transcripts and Leukemia Phenotype: An Unsolved Puzzle

References

• Groffen J., Stephenson J.R., Heisterkamp N., de Klein A., Bartram C.R., Grosveld G. Philadelphia chromosome breakpoints are clustered within a limited region, bcr, on chromosome 22. Cell 1984; 36: 93
   PubMed Web of Science ®Google Scholar
• Shtivelman E., Lifshitz B., Gale R.P., Roe B.A., Canaani E. Fused transcript of abl and bcr genes in chronic myeloid leukaemia. Nature 1985; 315: 550
   PubMed Web of Science ®Google Scholar
• Fainstein E., Marcelle C., Rosner A., Canaani E., Gale R.P., Dreazen, Smith S.D., Croce C.M. A new fused transcript in Philadelphia chromosome positive acute lymphocytic leukaemia. Nature 1987; 330: 386
   PubMed Web of Science ®Google Scholar
• Konopka J.B., Watanahe S.M., Witte O.N. An alteration of the human c-abl protein in K562 leukemia cells unmasks associated tyrosine kinase activity. Cell 1984; 37: 1035
   PubMed Web of Science ®Google Scholar
• Chan L.C., Karhi K.K., Rayter S.I., Heisterkamp N., Eridani S., Powles R., Lawler S.D., Groffen J., Foulkes J.G., Greaves M.F., Wiedemann L.M. A novel abl protein expressed in Philadelphia chromosome positive acute lymphoblastic leukaemia. Nature 1987; 325: 635
   PubMed Web of Science ®Google Scholar
• Lugo T.G., Pendcrgast A.-M., Muller A.J., Witte O.N. Tyrosine kinase activity and transformation potency of bcr-abl oncogene products. Science 1990; 247: 1079
   PubMed Web of Science ®Google Scholar
• McLaughlin J., Chianese E., Witte O.N. Alternative forms of the BCR-ABL oncogene have quantitatively different potencies for atimulation of immature lyniphoid cells. Mol Cell Biol 1989; 9: 1866–1874
   PubMed Web of Science ®Google Scholar
• Kurzrock R., Gutterman J.U., Talpaz M. The molecular genetics of Philadelphia chromosome-positive leukemias. N Engl J Med 1488; 319: 990
   Google Scholar
• Kelliher M., Knott A., McLaughlin J., Witte O.N., Rosenberg N. Differences in oncogenic potency hut not target cell specificity distinguish the two forms of the BCR/ABL oncogene. Mol Cell Biol 1941; 11: 4710–4716
   Google Scholar
• Voncken J.W., Kaartinen V., Pattengale P.K., Germeraad W. T. V., Groffen J., Heisterkamp N. BCR/ABL P210 and P190 cause distinct leukemia in transgenic mice. Blood 1995; 86(12)4603–4611
   PubMed Web of Science ®Google Scholar
• Sadamura S., Umemura T., Hirata J., Takahira H., Yufu Y., Yasunohu A., Nishimura J., Nawata H. P100-Type bcr/ahl expressed in myeloid colonics in a patient with Ph-positive acute lymphoblastic leukemia. Leukemia 1992; 6(8)791–795
   PubMed Web of Science ®Google Scholar
• Serra A., Guerasio A., Gaidano G., Rosso C., Rege-Cambrin G., Petroni D., Mazza U., Saglio G. Molecular defects associated with the acute phase CML. Leukemia and Lymphoma 1993; 11: 25–28
   PubMed Web of Science ®Google Scholar
• Sill H., Goldman J.M., Cross N. C. P. Homozygous deletions of the p16 tumor-suppressor gene are associated with lymphoid transformation of chronic mycloid leukemia. Blood 1995; 85: 2013–2016
   PubMed Web of Science ®Google Scholar
• Selleri I., von Lindern M., Hermans A., Meijer D., Torelli G., Grosveld G. Chronic myeloid leukemia may be associated with several bcr-abl transcripts including the acute lymphoid-type 7 kb transcript. Blood 1990; 75: 1146
   PubMed Web of Science ®Google Scholar
• Zaccaria A., Tassinari A., Testoni N., Lauria F., Tura S., Algeri R., Guerrasio A., Rosso C., Saglio G. Alternative hcr/abl transcripts in chronic myeloid leukemia. Blood 1990; 76: 1663
   PubMed Web of Science ®Google Scholar
• Guo J.Q., Hirsch-Ginsberg G.F., Xian Y.M., Stass S.A., Champlin R.E., Giralt S.A., McCredle K.B., Campbell M.L., Arlinghaus R.B. Acute lymphoid leukemia molecular phenotype in a patient with benign-phase chronic myelogenous leukemia. Hematol Pathol 1993; 7: 91
   PubMedGoogle Scholar
• Melo J.V., Myinr H., Galton D. A. C., Goldman J.M. P190 bcr/abl chronic rnyelomonocytic leukemia?. Leukemica 1994; 8: 208
   PubMed Web of Science ®Google Scholar
• Kirk J.A., Radich J., Edmands S., Lee A., VanDevanter D.R., Reems J.A., Bryant E.M. Unusual expression of mRNA typical of Philadelphia positive acutc lymphoblahtic leukemia detected in chronic inyeloid leukemia. American Journal of Hematology 1996; 52: 129–134
   PubMed Web of Science ®Google Scholar
• Saglio G., Pane F., Gottardi E., Frigeri F., Buonaiuto M.R., Guerrasio A., De Micheli D., Parziale A., Fornaci M.N., Martinelli G., Salvatore F. Consistent amounts of acute leukemia-asaociatcd P190 bcr/abl transcripts are expressed by chronic myelogenous leukemia patients at diagnosis. Blood 1996; 87(3)1075–1080
   PubMed Web of Science ®Google Scholar
• Van Rhee F., Hochhaus A., Lin F., Melo V., Goldman J.M., Cross N.C. p190 BCR/ABL mRNA is expressed at low levels in p210-positive chronic myeloid and acute lymphoblastic leukemias. Blood 1996; 87: 5213–5217
   PubMed Web of Science ®Google Scholar
• Dhingra K., Talpaz M., Kantarjian H.M., Ku S., Rothberg J., Gutterinan J.U., Kurzrock R. Appearance of acute leukemia-associated p 190 BCR-ABL in chronic myeloid leukemia may correlate with disease progression. Leukemia 1991; 5: 191
   PubMed Web of Science ®Google Scholar
• Guo J.Q., Wang J. Y. J., Arlinghaus R.B. Detection of BCR-ABL proteins in blood cells of benign phase chronic myelogenous leukcmia patients. Cancer Research 1991; 51: 3048–3051
   PubMed Web of Science ®Google Scholar
• Guo J.Q., Lian J.Y., Xian Y.M., Lee M.S., Deisseroth A.B., Stass S.A., Champlin R.E., Talpaz M., Wang J. Y. L., Arlinghaus R.B. BCR-ABL protein expression in peripheral blood cells of chronic myclogenous leukemia palienls undergoing therapy. Blood 1994; 83(12)3629–3637
   PubMed Web of Science ®Google Scholar
• Katsuno M., Yamashita S., Sadamura S., Umemura T., Hirata J., Nishimura J., Nawara H. Late-appearing Philadelphia chromosome in a patient with acute non-lymphocytic leukaemia derived from inyelodysplastic synndrome : detection of P210- and P190-type bcr/ahl fusion gene transcripts at the leukaeinic stage. British Journal of Haematology 1994; 87: 51–56
   PubMed Web of Science ®Google Scholar
• Williams B.G., Yin J.L., Ma D.D. A Ph+acute myeloid leukaemia expressing both CML-type and ALL-type BCR/ABL mRNA transcripts. Leukemia & Lymphoma 1994; 14: 341–346
   PubMed Web of Science ®Google Scholar
• Kantarjian H.M., Keating M.J., Talpaz M., Walters R.S., Smith T.L., Cork A., McCredie K.B., Freireich E.J. Chronic myelogenous leukemia in blast crisis. Analysis of 242 patients. American Journal of Medicine 1987; 83: 445–454
   PubMed Web of Science ®Google Scholar
• Cabot G.P., Bentz M., Scholl C., Moos M., Fischer K., Lichter P., Dohner H. High incidence of a second BCR/ABL fusion in chronic myeloid leukemia revealed by interphase cytogenetic analysis on blood and bone marrow smears. Cancer Genetic & Cytogenetic 1996; 87: 107–111
   PubMed Web of Science ®Google Scholar
• Pane F., Frigeri F., Sindone M., Luciano L., Ferrara F., Cimino R., Meloni C., Saglio G., Salvatore F., Rotoli B. Neutrophilic-chronic rnyeloid leukemia : A distinct disease with a specific molecular marker (BCR/ABL with C3/A2 junction). Blood 1996; 88: 2410–2414
   PubMed Web of Science ®Google Scholar
• Wada H., Mizutani S., Nishimura J., Usuki Y., Kohsaki M., Komai M., Kaneko H., Sakamoto S., Delia D., Kanamaru A., Kakishita E. Establishment and molecular characterization of a novel leukemic cell line with Philadelphia chromosome expressing p230 BCW/ABL fusion protein. Cancer Research 1995; 55: 3192–3196
   PubMed Web of Science ®Google Scholar
• Saglio G., Guerrasio A., Rosso C., Zaccaria A., Tassinari A., Serra A., Rege-Cambrin G., Mazza U., Gavosto F. New type of BCWABL junction in Philadelphia chromosome-positive chronic myelogenous leukemia. Blood 1990; 76: 1819–1824
   PubMed Web of Science ®Google Scholar
• Stewart M.J., Cox G., Reifel-Miller A., Kim S.Y., Westhrook C.A., Leihowitz D.S. A novel transcriptional suppresvor located within a downstream intron of the BCR gene. Journal of Biological Chemistry 1994; 269: 10820
   PubMed Web of Science ®Google Scholar
• Mostarda I., Buonaiuto M.R., Luciano L., Parasole R., Kotoli B., Saglio G., Salvatore F. Quantitative RT-PCR analysis detects variations in BCR/ABL tranacription rate in IFN-responder CML patients. Experimental Hematology 1996; 24(9)1133
   Google Scholar
• Gaiger A., Henn T., Horth E., Geissler G., Mitterbauer G., Maier-Dohersherger T., Greinix H., Mannhalter C., Haas O.A., Lechner K., Lion T. Increase of BCR/ABL chimeric mRNA expression in tumor cells of patients with chronic myeloid leukemia precedes disease progression. Blood 1995; 86: 2371–2378
   PubMed Web of Science ®Google Scholar